Endovelle

Endovelle is a medication containing dienogest, used for hormonal therapy. It is commonly prescribed for managing endometriosis symptoms and may support menstrual regulation. This oral medication is manufactured by Exeltis Healthcare S.L.

Endovelle, containing dienogest, is primarily used for the management of endometriosis. Endometriosis is a condition where tissue similar to the lining of the uterus grows outside the uterus, causing pain and other symptoms. Dienogest works by regulating hormonal levels, which can help alleviate pain and reduce the growth of endometrial tissue. It may also be used to manage heavy menstrual bleeding and other related symptoms.

Common effects of Endovelle may include changes in menstrual bleeding patterns, such as lighter or irregular periods. Some users may experience mild headaches, nausea, or breast tenderness. These effects are generally temporary and may vary among individuals. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Endovelle should be used with caution in individuals with a history of blood clots, liver disease, or certain types of cancer. It is important to inform your healthcare provider about any pre-existing conditions or allergies before starting this medication. Regular monitoring may be recommended to ensure safety and effectiveness.

Endovell may interact with certain medications, including those that affect liver enzymes, such as CYP3A4 inhibitors or inducers. It is advisable to avoid alcohol while taking this medication, as it may increase the risk of side effects. Always consult a healthcare provider before combining Endovelle with other medications.